Target intelligence / Profile preview

Glomerular mesangial cell proliferation (MCP)

Target
MCP
Molecular classification
Other
01

Overview

Glomerular mesangial cell proliferation is a pathological biological process characterized by the abnormal multiplication of mesangial cells within the kidney's glomeruli. It serves as a primary histological feature and driver of various progressive renal diseases, including IgA nephropathy, diabetic nephropathy, and lupus nephritis. This cellular expansion is typically triggered by injury-induced growth factors, most notably Platelet-Derived Growth Factor (PDGF) and Transforming Growth Factor-beta (TGF-beta), which activate signaling cascades such as the Ras/MAPK and PI3K/Akt pathways. Uncontrolled proliferation leads to excessive production of extracellular matrix (ECM), resulting in mesangial expansion and eventually progressing to irreversible glomerulosclerosis and end-stage renal disease. Therapeutic intervention strategies focus on inhibiting the molecular drivers of this process rather than the proliferation itself as a single target. Common pharmacological approaches include the use of ACE inhibitors and ARBs to reduce hemodynamic triggers, immunosuppressants to control underlying inflammation, and experimental inhibitors targeting tyrosine kinases or cyclin-dependent kinases to arrest the cell cycle. Monitoring the progression or resolution of mesangial cell proliferation in clinical settings involves assessing biomarkers like proteinuria and renal function, as well as evaluating histopathological scores from renal biopsies. Understanding the regulation of this process remains critical for developing targeted therapies to preserve renal architecture and function.

Other names
Mesangial cell proliferationMesangial hypercellularityMesangial hyperplasiaGlomerular mesangial expansionMC proliferation
02

Mechanism of action

Inhibition of mitogenic growth factor signaling (e.g., PDGF and TGF-beta pathways), induction of cell cycle arrest through cyclin-dependent kinase (CDK) inhibition, reduction of intraglomerular hemodynamic pressure, and suppression of inflammatory cytokine production.

03

Biological functions

Cell proliferationCell cycleSignal transductionExtracellular matrix productionTissue remodeling
04

Disease associations

InflammationDiabetic nephropathyIgA nephropathyLupus nephritisChronic kidney diseaseOther
05

Safety considerations

Systemic immunosuppression risksElectrolyte imbalancesPotential nephrotoxicity of certain kinase inhibitorsHypotension with hemodynamic modulatorsReduced renal regenerative capacity
06

Interacting drugs

10 more in the full profile.

07

Biomarkers

ProteinuriaSerum creatinineGlomerular filtration rate (GFR)Mesangial hypercellularity (M score in Oxford Classification)Urinary microRNA-21Urinary microRNA-192

Beyond the preview

Go deeper on Glomerular mesangial cell proliferation (MCP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glomerular mesangial cell proliferation (MCP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call